BCRX
BioCryst Pharmaceuticals (BCRX)
$33
About BioCryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Details
Daily high
$10.45
Daily low
$9.99
Price at open
$10.40
52 Week High
$11.11
52 Week Low
$5.92
Market cap
2.2B
Dividend yield
0.00%
Volume
4.5M
Avg. volume
6.8M
P/E ratio
-40.15
BioCryst Pharmaceuticals News
Details
Daily high
$10.45
Daily low
$9.99
Price at open
$10.40
52 Week High
$11.11
52 Week Low
$5.92
Market cap
2.2B
Dividend yield
0.00%
Volume
4.5M
Avg. volume
6.8M
P/E ratio
-40.15